Body Mass Index, Weight Loss, and Mortality Risk in Advanced-Stage Non-Small Cell Lung Cancer Patients: A Focus on EGFR Mutation

Body mass index (BMI) influences the prognosis of patients with non-small cell lung cancer (NSCLC), including both early-stage and late-stage NSCLC patients that are undergoing chemotherapies. However, earlier research on the relationship between BMI and survival in patients taking epidermal growth...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Yu-Mu, Lai, Chien-Hao, Lin, Chiung-Yu, Tsai, Yi-Hsuan, Chang, Ya-Chun, Chen, Hung-Chen, Tseng, Chia-Cheng, Chang, Huang-Chih, Huang, Kuo-Tung, Chen, Yung-Che, Fang, Wen-Feng, Wang, Chin-Chou, Chao, Tung-Ying, Lin, Meng-Chih
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8622618/
https://www.ncbi.nlm.nih.gov/pubmed/34836017
http://dx.doi.org/10.3390/nu13113761

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8622618/
https://www.ncbi.nlm.nih.gov/pubmed/34836017
http://dx.doi.org/10.3390/nu13113761

Ejemplares similares